MedPath

Multicenter cohort study identifying prognostic factors in patients with polymyositis/dermatomyositis and interstitial lung disease

Not Applicable
Conditions
polymyositis/dermatomyositis with interstitial lung disease
Registration Number
JPRN-UMIN000018663
Lead Sponsor
Anti-CADM-140 Antibody Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Observation period < 6 months unless death

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival at 3, 6, and 12 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath